Upstream Bio Appoints Allison Ambrose as General Counsel
17 déc. 2024 08h00 HE
|
Upstream Bio
Upstream appoints Allison Ambrose as General Counsel
Upstream Bio Announces Addition to Russell 2000® Index
16 déc. 2024 08h00 HE
|
Upstream Bio
Upstream Bio (Nasdaq:UPB) to be added to Russell 2000® index effective at the open of the U.S. equities market on Monday, December 23.
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
21 nov. 2024 08h00 HE
|
Upstream Bio
Upstream Bio CEO to participate in fireside chat at Piper Sandler
COPD and Asthma Devices Market Projected to Reach $44.95 Billion in 2024 with Continued Expansion through 2028, Driven by Technological Innovations and Rising Prevalence - Forecasts to 2033
07 nov. 2024 09h23 HE
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2024" report has been added to ResearchAndMarkets.com's offering. ...
Acute Respiratory Distress Syndrome Research Report 2024: Market to Grow at a CAGR of 8.7% During 2025-2030, Driven by Technological Advances in Diagnostics and Therapies
23 oct. 2024 06h28 HE
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration,...
Intelligent Asthma Monitoring Devices Market Research 2024: Partnerships Between Pharma and Smart Inhaler Firms to Revolutionize Asthma Management - Global Long-term Forecasts to 2028 and 2033
17 oct. 2024 04h01 HE
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Intelligent Asthma Monitoring Devices Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The intelligent asthma monitoring...
Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Pfizer, GSK, Novartis, Astellas, Abbott, Boehringer Ingelheim, Almirall
10 sept. 2024 05h12 HE
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis,...
United States Pulmonary/Respiratory Diseases KOLs Fair-Market Value Compensation Rates Report: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)
10 juil. 2024 05h29 HE
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The " Fair-Market Value Compensation Rates for Pulmonary/Respiratory Diseases KOLs - United States" report has been added to ResearchAndMarkets.com's...
Emerging Respiratory Care Companies, 2024: Strategic Profiles and Growth Opportunities to 2028
26 juin 2024 06h50 HE
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Emerging Respiratory Care Companies: Strategic Profiles and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.This...
Global Cystic Fibrosis Market Report 2024: Growth Amid Rising Prevalence and Innovative Therapeutic Developments - Forecasts to 2029
21 juin 2024 06h58 HE
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. Emerging Therapeutics and...